Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 14;44(27):2495-2497.
doi: 10.1093/eurheartj/ehad099.

Dysregulated Ca2+ cycling in atrial fibrillation

Affiliations
Editorial

Dysregulated Ca2+ cycling in atrial fibrillation

Julie H Rennison et al. Eur Heart J. .

Abstract

Atrial contractility is regulated by intracellular calcium levels; these reflect the balance of calcium influx, sequestration, and efflux. Beta-adrenergic activation with either norepinephrine (endogenous) or isoproterenol (pharmacological) increases the activity of adenylate cyclase, increasing cAMP levels and protein kinase A (PKA) activity. Degradation of cAMP is regulated by phosphodiesterases (PDEs). The phosphorylation state of relevant PKA targets, such as the L-type calcium channel (LTCC), the sarcoplasmic reticulum Ca2+-ATPase (SERCA2a), and myofilament proteins, is regulated by the balance of PKA activity and phosphatase activity. In patients with no history of atrial fibrillation (AF) or paroxysmal AF (pAF), basal phosphorylation of key LTCC subunits is higher than in atrial myocytes from patients with chronic (persistent) AF. Pavlidou et al. provide novel evidence that this is probably due to increased abundance and activity of phosphodiesterase isoform 8B, variant 2 (PDE8B2), in patients with chronic AF.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest None declared.

Figures

Graphical Abstract
Graphical Abstract
Atrial contractility is regulated by intracellular calcium levels; these reflect the balance of calcium influx, sequestration, and efflux. Beta-adrenergic activation with either norepinephrine (endogenous) or isoproterenol (pharmacological) increases the activity of adenylate cyclase, increasing cAMP levels and protein kinase A (PKA) activity. Degradation of cAMP is regulated by phosphodiesterases (PDEs). The phosphorylation state of relevant PKA targets, such as the L-type calcium channel (LTCC), the sarcoplasmic reticulum Ca2+-ATPase (SERCA2a), and myofilament proteins, is regulated by the balance of PKA activity and phosphatase activity. In patients with no history of atrial fibrillation (AF) or paroxysmal AF (pAF), basal phosphorylation of key LTCC subunits is higher than in atrial myocytes from patients with chronic (persistent) AF. Pavlidou et al. provide novel evidence that this is probably due to increased abundance and activity of phosphodiesterase isoform 8B, variant 2 (PDE8B2), in patients with chronic AF.

Comment on

References

    1. Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J 2012;33:1870–1877. 10.1093/eurheartj/ehs079 - DOI - PubMed
    1. Reinhardt F, Beneke K, Pavlidou NG, Conradi L, Reichenspurner H, Hove-Madsen L, et al. . Abnormal calcium handling in atrial fibrillation is linked to changes in cyclic AMP dependent signaling. Cells 2021;10:3042. 10.3390/cells10113042 - DOI - PMC - PubMed
    1. Attuel P, Childers R, Cauchemez B, Poveda J, Mugica J, Coumel P. Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. Int J Cardiol 1982;2:179–197. 10.1016/0167-5273(82)90032-8 - DOI - PubMed
    1. Boutjdir M, Le Heuzey JY, Lavergne T, Chauvaud S, Guize L, Carpentier A, et al. . Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol 1986;9:1095–1100. 10.1111/j.1540-8159.1986.tb06676.x - DOI - PubMed
    1. Allessie MA, Wijffels MC, Kirchhof CJ. Experimental models of arrhythmias: toys or truth? Eur Heart J 1994;15:2–8. 10.1093/eurheartj/15.suppl_a.2 - DOI - PubMed